NASDAQ
5.96USD
+0.26 (+4.47%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
566.7M
P/E
—
EPS
—
Beta
-0.04
52W range
1.39-7.44
Day range
5.72–6.01
Open
5.78
Prev close
5.71
Volume
930.1K
Avg volume
1.1M
Dividend
0.00
IPO
2023-03-21
https://www.defenseworld.net/2026/07/19/corvus-pharmaceuticals-nasdaqcrvs-trading-up-5-1-should-you-buy.html · 7/19/2026+0.60
https://www.defenseworld.net/2026/07/19/simmons-first-national-nasdaqsfnc-sees-large-volume-increase-heres-why.html · 7/19/2026+0.50
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
